Cipla Bommasandra facility gets VAI classification from USFDA Written By Ruchika Sharma5 Aug 2025 11:54 AM ISTMumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the current Good Manufacturing Practices (cGMP)...
Eli Lilly expands India presence with inauguration of Hyderabad site Ruchika Sharma5 Aug 2025 10:54 AM ISTHyderabad: Eli Lilly and Company (India) has announced the opening of its new technology and innovation site in Hyderabad; a new strategic hub...
Setback To Novartis: CDSCO Panel Rejects Lanalumab Phase III Trial Design Over Study Flaws Written By Dr. Divya Colin4 Aug 2025 6:00 PM ISTNew Delhi: In a setback to Novartis, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has declined to...
Kerala Medical Services Corporation not procured rabies vaccine without CDL certificate: Health Minister Ruchika Sharma4 Aug 2025 4:23 PM ISTNew Delhi: The Kerala Medical Services Corporation (KMSCL) has not procured or distributed any batch of rabies vaccine or equine anti-rabies...
Over 5 lakh Tramadol, Alprazolam tablets worth Rs 20 crore seized,; 5 arrested Written By Ruchika Sharma4 Aug 2025 1:21 PM ISTNew Delhi: The Narcotics Control Bureau (NCB) has uncovered a syndicate involved in illegally diverting pharma drugs across Uttar Pradesh and...
Roche Susvimo maintains vision over five years with two refills per year in people with nAMD Written By Ruchika Sharma4 Aug 2025 12:30 PM ISTBasel: Roche has announced new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the...
Fire erupts at Dey's Medical plant in Kolkata, no injuries reported Ruchika Sharma4 Aug 2025 11:30 AM ISTKolkata: Panic swept through the Bondel Gate area of south Kolkata on Saturday afternoon as a fire erupted at the Dey's Medical manufacturing...
One-shot Dengue vaccine 'DengiAll' completes 70% enrolment of participants in Phase III trial: Centre Written By Ruchika Sharma3 Aug 2025 2:45 PM ISTNew Delhi: Seventy per cent of participant enrolment has been completed for the Phase III clinical trial of indigenous one-shot dengue vaccine,...
Senores Pharma appoints Sanjay Moralwar as Head of IT Ruchika Sharma3 Aug 2025 1:00 PM ISTAhmedabad: Senores Pharma has announced the appointment of Sanjay Moralwar as Head of Information Technology."Excited to welcome Mr. Sanjay...
CDSCO Panel Recommends Approval for Vorasidenib with Phase-III Waiver, Mandates Phase-IV Trial in India Dr. Divya Colin3 Aug 2025 12:00 PM ISTNew Delhi: In response to a proposal by Servier India Pvt. Ltd. seeking approval to import and market the anti-cancer drug Vorasidenib Tablets 10 mg...
SIL declares profit from operations growth as +6% vs previous year Ruchika Sharma3 Aug 2025 11:30 AM ISTMumbai: Sanofi India Limited has announced its financial results for the quarter ended June 30, 2025.The Company recorded a 9% decline in net...
Novartis Told to Revise Protocol, Justify Sample Size in ITU512 Clinical Trial Proposal Parthika Patel3 Aug 2025 9:30 AM ISTNew Delhi: Novartis Healthcare Private Limited has been directed by the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
